scholarly journals Targeting cryptic epitope with modified antigen coupled to the surface of liposomes induces strong antitumor CD8 T-cell immune responses in vivo

2015 ◽  
Vol 34 (6) ◽  
pp. 2827-2836 ◽  
Author(s):  
YUTAKA HORIUCHI ◽  
AKIRA TAKAGI ◽  
TETSUYA UCHIDA ◽  
TOSHITAKA AKATSUKA
npj Vaccines ◽  
2021 ◽  
Vol 6 (1) ◽  
Author(s):  
Mauro Di Pilato ◽  
Miguel Palomino-Segura ◽  
Ernesto Mejías-Pérez ◽  
Carmen E. Gómez ◽  
Andrea Rubio-Ponce ◽  
...  

AbstractNeutrophils are innate immune cells involved in the elimination of pathogens and can also induce adaptive immune responses. Nα and Nβ neutrophils have been described with distinct in vitro capacity to generate antigen-specific CD8 T-cell responses. However, how these cell types exert their role in vivo and how manipulation of Nβ/Nα ratio influences vaccine-mediated immune responses are not known. In this study, we find that these neutrophil subtypes show distinct migratory and motility patterns and different ability to interact with CD8 T cells in the spleen following vaccinia virus (VACV) infection. Moreover, after analysis of adhesion, inflammatory, and migration markers, we observe that Nβ neutrophils overexpress the α4β1 integrin compared to Nα. Finally, by inhibiting α4β1 integrin, we increase the Nβ/Nα ratio and enhance CD8 T-cell responses to HIV VACV-delivered antigens. These findings provide significant advancements in the comprehension of neutrophil-based control of adaptive immune system and their relevance in vaccine design.


2019 ◽  
Vol 9 (6) ◽  
pp. 1095-1105 ◽  
Author(s):  
Qiuqiang Chen ◽  
Ying Bao ◽  
Danielle Burner ◽  
Sharmeela Kaushal ◽  
Yu Zhang ◽  
...  

2012 ◽  
Vol 188 (5) ◽  
pp. 2111-2117 ◽  
Author(s):  
Jinwook Shin ◽  
Thomas F. O’Brien ◽  
Jason M. Grayson ◽  
Xiao-Ping Zhong

2004 ◽  
Vol 172 (5) ◽  
pp. 3094-3100 ◽  
Author(s):  
Richard J. Anderson ◽  
Carolyn M. Hannan ◽  
Sarah C. Gilbert ◽  
Stephen M. Laidlaw ◽  
Eric G. Sheu ◽  
...  

2001 ◽  
Vol 75 (18) ◽  
pp. 8690-8696 ◽  
Author(s):  
Yun Shen ◽  
Ling Shen ◽  
Prabhat Sehgal ◽  
Dejiang Zhou ◽  
Meredith Simon ◽  
...  

ABSTRACT The contribution of immune reconstitution following antiretroviral treatment to the prevention or treatment of human immunodeficiency virus-related primary or reactivation tuberculosis remains unknown. Macaque models of simian immunodeficiency virus-Mycobacterium bovis BCG (SIV/BCG) coinfection were employed to determine the extent to which anti-Mycobacterium tuberculosis immunity can be restored by antiretroviral therapy. Both SIV-infected macaques with active BCG reinfection and naive animals with simultaneous SIV/BCG coinfection were evaluated. The suppression of SIV replication by antiretroviral treatment resulted in control of the active BCG infection and blocked development of the fatal SIV-related tuberculosis-like disease. The resolution of this disease coincided with the restoration of BCG purified protein derivative (PPD)-specific T-cell immune responses. In contrast, macaques similarly coinfected with SIV/BCG but not receiving antiretroviral therapy had depressed PPD-specific primary and memory T-cell immune responses and died from tuberculosis-like disease. These results provide in vivo evidence that the restoration of anti-mycobacterial immunity by antiretroviral agents can improve the clinical outcome of an AIDS virus-related tuberculosis-like disease.


2002 ◽  
Vol 169 (8) ◽  
pp. 4262-4272 ◽  
Author(s):  
Radhakrishnan Suresh ◽  
Monika Vig ◽  
Sumeena Bhatia ◽  
Eric P. B. Goodspeed ◽  
Beena John ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document